10 completed, 2 not yet recruiting, 2 recruiting, 1 active not recruiting. 18 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 18 | Completed 10, Not yet recruiting 2, Recruiting 2, Active not recruiting 1, Suspended 1, Terminated 1, Unknown 1 |
Follow Left Ventricular Hypertrophy: new trials by email Literature Review of Left Ventricular Hypertrophy trials Research Report on Left Ventricular Hypertrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Detection of Cardiac Amyloidosis Using Right Ventricular Sensing Amplitude in Patients With Left Ventricular Hypertrophy Cardiac amyloidosis screening during CIED implantation - Cardiac Amyloidosis, Left Ventricular Hypertrophy | Not applicable | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 242 | 2026-09-01 | 2026-07-29 |
| AI-based Echocardiography for Detection of Cardiac Amyloidosis AI-based echocardiogram - Cardiac Amyloidosis, Heart Failure With Preserved Ejection Fraction (HFPEF) | Not applicable | Not yet recruiting | Germans Trias i Pujol Hospital | 200 | 2026-07-01 | 2026-06-12 |
| Evaluation of Left Ventricular Ejection Fraction Using an Accelerated Cardiac Cine-MRI Sequence With Deep Learning-based Image Reconstructions accelerated cardiac cine-MRI sequence - Left Ventricular Ejection Fraction, Cardiac Magnetic Resonance Imaging | Not applicable | Recruiting | Centre Hospitalier Universitaire, Amiens | 61 | 2025-08-05 | 2026-01-16 |
| Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy Customized discharge and expedited referral instructions - Left Ventricular Hypertrophy | Not applicable | Completed | Yale University | 165 | 2023-10-15 | 2026-05-29 |
| Sodium Lowering Vascular Effects Trial Sodium Reduction Intervention - Endothelial Dysfunction, Vascular Stiffness | Not applicable | Active not recruiting | Tulane University | 256 | 2023-01-25 | 2026-10-01 |
| Protective Monocytes and Macrophages to Limit Decompensation and Heart Damaging Blood sampling - Left Ventricular Hypertrophy | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 75 | 2019-10-15 | 2019-07-25 |
| Imaging Histone Deacetylase in the Heart 11C-Martinostat, PET-MRI - Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy | Not applicable | Recruiting | Massachusetts General Hospital | 96 | 2018-09-07 | 2025-12-22 |
| Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient detailed echocardiography, serum fibroblast growth factor-23, flow mediated dilatation of forearm - Anemia of Chronic Kidney Disease, Endothelial Dysfunction | Not applicable | Suspended | Omnia Mohammed Hashem | 80 | 2018-09-01 | 2018-06-27 |
| Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose) Tissue biopsies - Left Ventricular Hypertrophy | Not applicable | Completed | University Hospital Center of Martinique | 175 | 2013-09-23 | 2017-10-27 |
| Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome Armolipid Plus, Placebo - Metabolic Syndrome, Insulin-resistance | Not applicable | Completed | Rottapharm | 159 | 2013-04-01 | 2015-10-27 |
| Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients cholecalciferol (Vitamin D), Placebo - Hypertension, Left Ventricular Hypertrophy | Not applicable | Completed | Wayne State University | 354 | 2011-08-01 | 2015-12-09 |
| The Effect of Heart Rate on Cardiac Index in Patients With Left Ventricular Hypertrophy Pacemaker - Left Ventricular Hypertrophy, Diastolic Dysfunction | Not applicable | Terminated | University of Aarhus | 11 | 2011-02-01 | 2012-08-06 |
| The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients Decreasing dialysate sodium from 138 mmol/L to 136 mmol/L - Hypertension, Arteriosclerosis | Not applicable | Completed | Capital Medical University | 16 | 2010-10-01 | 2011-10-20 |
| Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension stress echocardiography - Hypertension, Left Ventricular Hypertrophy | Not applicable | Completed | Mustafa Kemal University | 60 | 2009-06-01 | 2011-09-29 |
| Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan losartan - Renal Failure, Left Ventricular Hypertrophy | Not applicable | Completed | Melbourne Health | 52 | 2006-10-01 | 2015-05-12 |
| Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression Bendroflumethiazide 2.5mg OD; Amlodipine 10mg OD, Valsartan 160mg OD; Moxonidine 400mcg OD - Hypertension, Left Ventricular Hypertrophy | Not applicable | Completed | University of Leeds | 42 | 2003-09-01 | 2012-08-16 |
| Hypertension in Hemodialysis Ultrafiltration - Hypertension, Left Ventricular Hypertrophy | Not applicable | Completed | Indiana University | 150 | 2003-08-01 | 2011-03-28 |
| Stress Reduction in the Prevention of Left Ventricular Hypertrophy meditation, Health education control - Left Ventricular Hypertrophy, High Blood Pressure | Not applicable | Completed | Maharishi International University | 171 | 1996-04-01 | 2022-05-13 |
Hypertrophy, Left Ventricular (18) · Hypertension (6) · Amyloid Neuropathies, Familial (3) · Aortic Valve Stenosis (1) · Arteriosclerosis (1) · Arteriovenous Fistula (1) · Diabetes Mellitus (1) · Disease (1) · Heart Failure (1) · Hypertrophy (1) · Insulin Resistance (1) · Metabolic Syndrome (1) · Renal Insufficiency (1) · Sprains and Strains (1) · Ventricular Dysfunction, Left (1)
Cardiomegaly (18) · Cardiovascular Diseases (18) · Heart Diseases (18) · Pathological Conditions, Anatomical (18) · Pathological Conditions, Signs and Symptoms (18) · Hypertrophy (17) · Vascular Diseases (7) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Amyloid Neuropathies (3) · Amyloidosis (3) · Amyloidosis, Familial (3) · Genetic Diseases, Inborn (3) · Heredodegenerative Disorders, Nervous System (3)
Amlodipine (1) · Bendroflumethiazide (1) · Blood Specimen Collection (1) · Cholecalciferol (1) · Losartan (1) · Meditation (1) · Mindfulness-Based Stress Reduction (1) · Ultrafiltration (1) · Valsartan (1) · Vitamin D (1) · martinostat (1) · moxonidine (1)
Assistance Publique - Hôpitaux de Paris (2) · Capital Medical University (1) · Centre Hospitalier Universitaire, Amiens (1) · Germans Trias i Pujol Hospital (1) · Indiana University (1) · Maharishi International University (1) · Massachusetts General Hospital (1) · Melbourne Health (1) · Mustafa Kemal University (1) · Omnia Mohammed Hashem (1) · Rottapharm (1) · Tulane University (1) · University Hospital Center of Martinique (1) · University of Aarhus (1) · University of Leeds (1)
United States (5) · France (2) · Australia (1) · China (1) · Denmark (1) · Egypt (1) · Guadeloupe (1) · Italy (1) · Martinique (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Anuradha Aggarwal (1) · Eugenia Pedagogos, FRACP,PhD (1) · Fatih Yalcin, MD (1) · John P Greenwood, MBChB, PhD (1) · Katherine T Mills, PhD (1) · Mohammed Ali Tohamy, professor (1) · Peter Juhl-Olsen, M.D. (1) · Philippe Le Corvoisier, MD, PhD (1) · Phillip D Levy, MD (1) · Robert H Schneider, M.D. (1) · Victoria Delgado Garcia, MD, PhD (1)
PMID 17389264, PMID 19153263, PMID 19515473, PMID 19528362, PMID 20038754, PMID 20167684, PMID 21330484, PMID 22642740, PMID 23505057, PMID 25803389, PMID 26394828, PMID 26437603, PMID 26439537, PMID 26787561, PMID 31371114, PMID 31641325
R01DK062030 (1)